首页|血清miR-149、miR-132水平与高危型HPV阳性感染者宫颈癌发生的关系

血清miR-149、miR-132水平与高危型HPV阳性感染者宫颈癌发生的关系

扫码查看
目的 探究血清miR-149、miR-132 与高危型HPV阳性感染者宫颈癌发生的关系.方法 选取2021年4月至2023年4月成都市第一人民医院收治的75例高危型HPV阳性宫颈癌患者为研究组,选取同期75例高危型HPV阳性感染者为对照组.采用qRT-PCR检测研究两组血清miR-149、miR-132水平.采用Pearson相关分析血清miR-149、miR-132水平的相关性.采用Logistic回归分析高危型HPV阳性感染者发生宫颈癌的影响因素.采用受试者工作特征(ROC)曲线分析血清miR-149、miR-132水平预测高危型HPV阳性感染者发生宫颈癌的临床价值.结果 与对照组相比,研究组血清miR-149、miR-132水平均显著下降,差异有统计学意义(P<0.05).Pearson分析结果显示,高危型HPV阳性宫颈癌患者血清miR-149 水平与miR-132 水平呈正相关(P<0.001).血清miR-149 高表达、miR-132高表达是高危型HPV阳性感染者发生宫颈癌的保护因素(P<0.05).血清miR-149、miR-132水平单独及二者联合预测高危型HPV阳性感染者发生宫颈癌的曲线下面积(AUC)分别为 0.849、0.895 和 0.918,二者联合优于血清 miR-149 单独预测(P=0.002).结论 高危型 HPV 阳性宫颈癌患者血清中miR-149、miR-132呈低表达,二指标与高危型HPV阳性感染者宫颈癌的发生密切相关.
The relationship between serum miR-149,miR-132 and the occurrence of cervical cancer in high-risk HPV positive patients
Objective To explore the relationship between serum miR-149,miR-132 and the oc-currence of cervical cancer in high-risk HPV positive patients.Methods From April 2021 to April 2023,75 high-risk HPV positive cervical cancer patients admitted to Chengdu First People's Hospital were regarded as the study group;75 high-risk HPV positive were regarded as the control group.QRT-PCR was applied to de-tect the serum levels of miR-149 and miR-132 in the study subjects.Pearson correlation was applied to analyze the correlation between serum levels of miR-149 and miR-132.Logistic regression was applied to analyze the influencing factors of cervical cancer in high-risk HPV positive patients.Receiver operating characteristic(ROC)curve was applied to analyze the clinical value of serum miR-149 and miR-132 levels in predicting the occurrence of cervical cancer in high-risk HPV positive patients.Results Compared with the control group,the serum levels of miR-149 and miR-132 in the study group were obviously reduced(P<0.05).Pearson's method showed a positive correlation between serum miR-149 level and miR-132 level in high-risk HPV posi-tive cervical cancer patients(P<0.001).The overexpression of miR-149 and miR-132 in serum were protective factors for cervical cancer in high-risk HPV-positive patients(P<0.05).The area under the curve(AUC)of se-rum miR-149 and miR-132 levels alone and in combination in predicting the occurrence of cervical cancer in high-risk HPV positive patients was 0.849,0.895,and 0.918,respectively,the combination of the two was better than the prediction of serum miR-149 alone(P=0.002).Conclusion MiR-149 and miR-132 are low ex-pressed in the serum of high-risk HPV positive cervical cancer patients,and they are closely related to the oc-currence of cervical cancer in high-risk HPV positive patients.

MiR-149MiR-132High-risk HPVCervical cancer

李彦、徐宁、李元宏、李敏、李梦茜

展开 >

成都市第一人民医院妇科,四川,成都 610041

miR-149 miR-132 高危型HPV 宫颈癌

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(12)